Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-23

Clinical Trial Update: Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants [Phase 1]

View source ↗

Summary

GSK reports results from a Phase 1 pharmacokinetic study of Green (Sustainable) Ventolin in healthy participants; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ventolin (albuterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2024-09-23